Amr Nassar
Overview
Explore the profile of Amr Nassar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
152
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hashmi S, Shaheen M, Adil S, Ahmed P, Ahmed S, Ben Abdeljelil N, et al.
Hematol Oncol Stem Cell Ther
. 2020 May;
16(4):303-306.
PMID: 32413418
No abstract available.
2.
Aldawsari G, Elhaddad A, El Fakih R, Othman T, Ahmed P, Ghavamzadeh A, et al.
Bone Marrow Transplant
. 2020 Feb;
55(7):1485-1490.
PMID: 32024988
Hematopoietic Stem Cell Transplantation (HSCT) is the only potentially curative treatment option for the hematologic complications that occur in patients with Fanconi anemia (FA). In this study, we present a...
3.
Aljurf M, Weisdorf D, Hashmi S, Nassar A, Gluckman E, Mohty M, et al.
Biol Blood Marrow Transplant
. 2019 Apr;
25(12):2330-2337.
PMID: 31002990
The development of hematopoietic stem cell transplantation (HSCT) programs can face significant challenges in most developing countries because such endeavors must compete with other government health care priorities, including the...
4.
Baldomero H, Aljurf M, Zaidi S, Hashmi S, Ghavamzadeh A, Elhaddad A, et al.
Bone Marrow Transplant
. 2018 Aug;
54(3):402-417.
PMID: 30082852
Hematopoietic Stem Cell Transplantation (HSCT) activity was evaluated in the African (AFR)/EMRO region and compared to the global activity for the years 2006-2013. Data were obtained from 1570 teams in...
5.
Hashmi S, Srivastava A, Rasheed W, Adil S, Wu T, Jagasia M, et al.
Hematol Oncol Stem Cell Ther
. 2017 Jul;
10(4):167-172.
PMID: 28732192
The hematopoietic cell transplant (HCT) activity has grown significantly over the past two decades in both developing and developed countries. Many challenges arise in establishing new HCT programs in developing...
6.
Aljurf M, Nassar A, Hamidieh A, Elhaddad A, Hamladji R, Bazarbachi A, et al.
Hematol Oncol Stem Cell Ther
. 2015 Oct;
8(4):167-75.
PMID: 26452331
Objective/background: The Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) group has accumulated over 31 years of data and experience in hematopoietic stem cell transplantation (HSCT), particularly in hemoglobinopathies, severe aplastic...
7.
Nassar A, Elgohary G, Elhassan T, Nurgat Z, Mohamed S, Aljurf M
J Transplant
. 2014 Nov;
2014:980301.
PMID: 25405023
Glucocorticoids have been the primary treatment of graft-versus-host disease (GVHD) over the past decade. Complete responses to steroid therapy are usually expected in almost one-third of aGVHD cases and partial...
8.
Nassar A, Tabbara K, Aljurf M
Saudi J Ophthalmol
. 2013 Nov;
27(3):215-22.
PMID: 24227989
Allogeneic hematopoietic stem cell transplantation (HSCT) has evolved over the past two decades to become the standard of care for hematologic and lymphoid malignancies. Major ocular complications after allogeneic HSCT...
9.
Bakr M, Rasheed W, Mohamed S, Al-Mohareb F, Chaudhri N, Al-Sharif F, et al.
Biol Blood Marrow Transplant
. 2012 Jul;
18(12):1897-904.
PMID: 22824185
Allogeneic hematopoietic stem cell transplantation (allo-SCT) is often recommended for patients with T cell acute lymphoblastic leukemia (T-ALL) in second or later complete remission (≥CR2) and sometimes in high-risk (HR)...
10.
Al-Zahrani H, Nassar A, Al-Mohareb F, Al-Sharif F, Mohamed S, Al-Anazi K, et al.
Biol Blood Marrow Transplant
. 2010 Aug;
17(5):717-22.
PMID: 20736079
Thirty-eight patients who met the diagnostic criteria for severe aplastic anemia underwent allogeneic hematopoietic stem cell transplantation (HSCT). The median patient age was 20 years (range, 14-36 years). Twenty-four patients...